Maybe not so. Ariad is pulling out the stops on these proxy measures and it looks like those intending to ward off suitors could fail.
The traders might move in here, could trigger some short covering. Maybe not.
Just for fun on this whole topic of 'cure for cml', at the last annual mmeting, HB said, "...that you can develop new medicines that actually really do make a difference and that can turn what used to be diseases that we couldn't treat into chronic diseases that we can either cure, which is within reach, I think, in the future with CML or certainly diseases that we can turn into chronic long-term diseases that patients can live with over long periods of time.."
seeking alpha
News 
Market Data 
Discover 
